GSK Enters Settlement to Purchase IDRx, Inc. By Investing.com
Acquisition contains IDRX-42, a extremely selective KIT tyrosine kinase inhibitor (TKI) designed…
GSK agrees to settle about 80,000 Zantac lawsuits for as much as $2.2 billion By Reuters
By Brendan Pierson (Reuters) -GSK has agreed to pay as much as…
